Bone Biologics (BBLG) stock experienced a significant drop of 20.23% on October 29, 20241. The decline in BBLG's stock price can be attributed to Recent Capital Raise.
The company recently announced a public share offering, revealing the sale of 2.53 million shares at a price of $1.97 each, expecting to raise $5 million. Such an offering can lead to a dilution of existing shareholders' stakes and is often perceived negatively by the market, as it might indicate the company's urgency for capital and could put downward pressure on the stock price2.